Talanx AG (TLX) AI Stock Analysis

• Market Cap: €26.90B
• Dividend Yield: 2.37%
• Average Volume (3M): 98.76K
• Price to Earnings (P/E): 11.9
• Beta (1Y): 0.91
• Revenue Growth: 3.70%
• EPS Growth: 24.02%
• Country: DE
• Employees: 29,357
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Diversified
• EPS (TTM): 2.00
• Shares Outstanding: 258,229,000
• 10 Day Avg. Volume: 108,935
• 30 Day Avg. Volume: 98,760
• PEG Ratio: 0.47
• Price to Book (P/B): 2.18
• Price to Sales (P/S): 0.51
• P/FCF Ratio: 3.71
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 10.62
• Revenue Forecast (FY): €52.05B

• Rating: 74 Outperform
• Price Target: €121.00 ▲(16.12% Upside)
• Action: Upgraded Date: 03/20/26
• Date: Action: Upgraded 03/20/26

The score is driven primarily by strong financial performance (improving earnings/returns, declining leverage, and robust cash generation). Valuation is supportive with a moderate P/E and a ~2.5% dividend yield. Technicals are only moderately positive, with the price still below longer-term moving averages and an elevated Stochastic suggesting momentum may be somewhat stretched.

Positive Factors

Cash generation

Consistently strong operating cash flow and nearly €8B FCF in 2025 indicate durable cash generation. Reliable free cash flow supports reserve funding, reinsurance purchases, dividends and capital allocation, providing financial flexibility across insurance cycles and enabling strategic investment without relying on volatile markets.

Improving balance sheet and capital productivity

Material deleveraging and rising equity alongside ROE expansion reflect stronger solvency and capital efficiency. Lower leverage reduces refinancing and liquidity risk, while higher ROE signals improved underwriting and investment returns—enhancing capacity to underwrite larger risks and absorb adverse loss periods over the medium term.

Diversified insurance and reinsurance franchise

Talanx’s mix of primary insurance lines and a significant reinsurance platform (Hannover Re) creates multiple, complementary income streams. Structural diversification across products and geographies smooths volatility, leverages underwriting scale, and allows cross-segment capital allocation—strengthening long-term earnings resilience.

Negative Factors

Revenue and margin volatility

Volatile top-line and a margin compression in 2025 after stronger 2023–24 results raise concerns about earnings persistence. Large year-to-year swings complicate planning for underwriting adequacy and pricing, making it harder to rely on 2025 metrics as a baseline for medium-term profit expectations.

Scale amplifies market and underwriting sensitivity

An exceptionally large asset base increases exposure to interest-rate moves, credit spreads and reserve volatility. Even with moderate leverage ratios, small percentage shocks in investment returns or claim reserves can materially affect solvency and capital requirements, making results more sensitive to macro and catastrophe events.

Reporting anomalies and one-off datapoint risk

Noted anomalies in 2025 coverage metrics and an anomalous operating cash flow coverage value reduce confidence in that year's comparability. Such reporting noise makes it harder to assess durable trends in cash conversion and underwriting quality, increasing the risk that short-term improvements are transitory or distorted.

Talanx AG Business Overview & Revenue Model

Company Description

Talanx AG provides insurance and reinsurance products and services worldwide. The company offers life, casualty, liability, motor, aviation, legal protection, fire, burglary and theft, water damage, plate glass, windstorm, comprehensive householders, comprehensive home-owners, hail, livestock, engineering, omnium, marine, business interruption, travel assistance, aviation and space liability, financial lines, and other property insurance, as well as coverage for fire and fire loss of profits insurance. It also provides bancassurance products; unit linked life insurance, annuity and risk insurance, and long term and occupational disability insurance products; personal accident insurance; and Sharia-compliant retakaful reinsurance products. The company offers property and casualty, marine and aviation, credit/surety, agriculture, structured, and life and health reinsurance, as well as engages in the facultative and nat cat, and asset management businesses. The company was founded in 1996 and is based in Hanover, Germany. Talanx AG operates as a subsidiary of HDI Haftpflichtverband der Deutschen Industrie Versicherungsverein auf Gegenseitigkeit.

How the Company Makes Money

Talanx makes money primarily through (1) insurance underwriting, (2) reinsurance underwriting, and (3) investment income on assets backing insurance liabilities and equity. 1) Primary insurance underwriting (premiums minus claims and expenses) - Talanx collects insurance premiums from individuals and businesses for coverage in lines such as property & casualty (e.g., motor, liability, property), life, and health. Revenue is earned as premiums are recognized over the coverage period. - Profitability depends on the difference between premiums earned and (a) claims and benefits paid/expected, (b) changes in technical reserves, (c) acquisition costs (commissions) and administrative expenses, and (d) reinsurance costs purchased to reduce volatility. - In commercial and industrial lines, pricing discipline, risk selection, and claims management are key drivers of underwriting results. 2) Reinsurance underwriting (Hannover Re) - Through Hannover Re, the group earns reinsurance premiums by assuming portions of risk from other insurers (cedants) across property & casualty and life/health reinsurance. - Earnings come from the underwriting margin (reinsurance premiums earned minus claims, commissions/ceding costs, and operating expenses) and are influenced by catastrophe losses, reserve development, contract terms (e.g., excess-of-loss vs. proportional treaties), and renewals/pricing in global reinsurance markets. 3) Investment income and asset management of the insurance float - Talanx invests the funds it holds to pay future claims and policy benefits (technical provisions) as well as shareholders’ equity. Income comes from interest on bonds/loans, dividends, rental income (if applicable), and realized/unrealized gains and losses, subject to the accounting and regulatory framework. - The level of interest rates, credit spreads, equity markets, and asset allocation materially affect investment results and the ability to price long-duration products (especially life and health). Additional factors that contribute to earnings - Fees and other income can arise from policy-related charges in certain life/health products and from services ancillary to insurance operations, but specific fee categories are not provided here. - Distribution and customer access are supported through the group’s operating brands and networks; specific partnership details are null. Significant partnerships or named counterparties: null.

Talanx AG Financial Statement Overview

Summary

Strong overall financial health: net income and EBIT increased materially over 2020–2025, leverage improved (debt-to-equity down to 0.63x in 2025), and operating/free cash flow remained robust (FCF €7.92B in 2025 with solid conversion vs earnings). Offsets include revenue volatility and a profitability step-down in 2025 versus 2023–2024, plus a questionable 2025 coverage datapoint that adds some reporting noise.

Income Statement

Profitability and scale improved materially over time, with net income rising from €0.65B (2020) to €2.48B (2025) and EBIT increasing from €1.45B to €5.07B. Margins are solid for a diversified insurer (net margin ~4.3% in 2025 vs ~1.7% in 2020), but profitability is not linear—net margin peaked in 2023–2024 (~7.7–8.2%) before compressing in 2025. Reported revenue is volatile (notably the sharp step-up in 2025), which adds uncertainty around the durability of the growth trajectory.

Balance Sheet

Leverage looks manageable and improving: debt-to-equity declined from 1.13x (2022) to 0.63x (2025), while equity expanded to €13.47B (2025) from €8.64B (2022). Returns on equity strengthened meaningfully (from ~8.2% in 2022 to ~18.4% in 2025), signaling better capital productivity. The main drawback is that absolute assets remain very large (€193.7B in 2025), which is typical for insurers but can amplify sensitivity to market/underwriting swings even when headline leverage ratios look reasonable.

Cash Flow

Cash generation is a clear strength: operating cash flow is consistently high (roughly €6.0B–€10.0B across 2020–2025) and free cash flow remains robust (€7.92B in 2025). Free cash flow closely tracks earnings (free cash flow to net income ~0.83–1.00 historically, ~0.95 in 2025), supporting earnings quality. Weaknesses include variability in free cash flow growth (including a decline in 2022) and an anomalous/possibly unreliable operating cash flow coverage figure in 2025 (shown as 0.0), which limits confidence in that specific indicator.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	23.20B	57.27B	25.58B	19.23B	18.73B	43.13B
Gross Profit	23.20B	57.27B	27.40B	20.35B	19.66B	33.69B
EBITDA	5.17B	5.42B	5.11B	3.22B	2.91B	2.67B
Net Income	2.26B	2.48B	1.98B	1.58B	706.00M	1.01B
Balance Sheet
Total Assets	177.29B	193.71B	180.42B	168.53B	193.13B	197.52B
Cash, Cash Equivalents and Short-Term Investments	120.02B	5.26B	123.34B	5.10B	95.53B	106.21B
Total Debt	7.84B	8.48B	8.90B	9.11B	9.78B	7.73B
Total Liabilities	159.04B	172.82B	161.92B	151.73B	180.54B	179.58B
Stockholders Equity	11.85B	13.47B	11.66B	10.45B	8.64B	10.78B
Cash Flow
Free Cash Flow	0.00	7.92B	8.43B	7.63B	5.77B	8.38B
Operating Cash Flow	0.00	8.37B	8.43B	8.10B	5.97B	10.05B
Investing Cash Flow	0.00	-5.76B	-6.79B	-5.03B	-6.86B	-10.06B
Financing Cash Flow	0.00	-2.02B	-1.58B	-1.49B	521.00M	428.00M

Talanx AG Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 104.20
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:TLX, the sentiment is Negative. The current price of 104.2 is below the 20-day moving average (MA) of 105.84, below the 50-day MA of 106.83, and below the 200-day MA of 110.76, indicating a bearish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 45.04 is Neutral, neither overbought nor oversold. The STOCH value of 51.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:TLX.

Talanx AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TLX	74 Outperform	€26.90B	11.85	19.71%	2.37%	3.70%	24.02%
HNR1	74 Outperform	€31.35B	12.16	21.53%	3.37%	2.57%	9.75%
ALV	71 Outperform	€131.63B	13.80	―	3.94%	25.33%	12.54%
MUV2	71 Outperform	€68.04B	8.78	19.40%	3.56%	0.48%	11.17%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
NBG6	65 Neutral	€1.39B	3.11	-0.98%	0.12%	-1.28%	-153.13%
WUW	53 Neutral	€1.49B	7.11	2.81%	4.49%	4.19%	-75.44%